GLPRX | SPNNX | GLPRX / SPNNX | |
Total Expense Ratio | 7.24 | 9.27 | 78% |
Annual Report Gross Expense Ratio | 7.24 | 9.27 | 78% |
Fund Existence | 12 years | 6 years | - |
Gain YTD | 2.377 | 4.647 | 51% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.62B | 3.91B | 41% |
Annual Yield % from dividends | 7.50 | 7.41 | 101% |
Returns for 1 year | 9.74 | 12.01 | 81% |
Returns for 3 years | 59.89 | 63.59 | 94% |
Returns for 5 years | 208.95 | 243.35 | 86% |
Returns for 10 years | 48.55 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PRHSX | 80.75 | 0.71 | +0.89% |
T. Rowe Price Health Sciences | |||
RSVAX | 25.66 | 0.06 | +0.23% |
Victory RS Value A | |||
HWSCX | 56.54 | 0.09 | +0.16% |
Hotchkis & Wiley Small Cap Value C | |||
RSDFX | 41.21 | -0.06 | -0.15% |
Columbia Dividend Opportunity Inst2 | |||
BCVCX | 32.27 | -0.15 | -0.46% |
Sterling Capital Behav Lg Cp Val Eq C |